ExoHCR: a sensitive assay to profile PD-L1 level on tumor exosomes for immunotherapeutic prognosis
Lujun Hu(Virginia Commonwealth University), Guizhi Zhu(University of Michigan), Shurong Zhou(University of Michigan), Wenjie Chen(Commercial Aircraft Corporation of China (China))
Cited by 6
Related Papers
Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines
|Journal of Controlled Release|2022|344
Hyaluronic Acid-Decorated Graphene Oxide Nanohybrids as Nanocarriers for Targeted and pH-Responsive Anticancer Drug Delivery
|ACS Applied Materials & Interfaces|2014|202
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
|Advanced Science|2022|73
Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases
|Accounts of Chemical Research|2023|71
Small GTPases: Structure, biological function and its interaction with nanoparticles
|Asian Journal of Pharmaceutical Sciences|2018|70